Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Alphasigma has first refusal for IBD, and is licensed only for UP and rectal issues. Yes? They signed cheaply knowing there was a targeting pill in development and that pill was likely to treat the entire lower bowel due to no absorption. Yes? And, further, an enema treatment would be second choice for physicians and patients if the enema was not vastly superior. This would be off-label, of course since AS would insist on their rights for on-label marketing. So, it would be not be in AS’s interest to exercise their rights? Or, perhaps sell the on-label rights to whoever got the IB platform for the pill.